About Rishab Dugar
Rishab is a financial journalist and investment analyst. His investment approach is to focus on quality stocks, trading at low prices, with business models that he readily understands.
Rishab majored in finance while at college and is currently a Level III candidate of the Chartered Financial Analyst (CFA) program.
Recent Articles By Rishab Dugar
Up 114% YTD, is Liquid Media Group Still a Buy?
Shares of Liquid Media (YVR) have been galloping this month because investors are bullish on the company’s potential as a non-fungible token (NFT) play. However, the company is not yet profitable and lacks adequate liquidity to finance its existing obligations. YVR has relied heavily on external financing but is now facing difficulties in raising capital in the current, uneasy financial markets. Furthermore, YVR is also facing some legal challenges. Hence, we think the stock is best avoided now.
3 Small-Cap Stocks that have High-Growth Potential
Small-cap companies are expected to outperform the broader market because they are more sensitive to macroeconomic movements than other companies. Government support checks, robust COVID-19 vaccine distribution and rising inflation are among the key factors that could drive the growth of small-cap stocks. We think Blueknight Energy Partners (BKEP), Ocean Bio-Chem (OBCI), and Live Ventures (LIVE) exhibit impressive earnings growth potential and could be solid bets now.
2 Buy-Rated Biotech Stocks Fighting Cancer
The cancer therapy market has been making a significant recovery following the biotech sector's success on the COVID-19 vaccine development front. Rising investment in cancer research and an increasing demand for personalized medicine present a remarkable opportunity for the cancer therapy market. Against this backdrop, investing in biotech stocks with diverse product portfolios, such as Exelixis (EXEL) and Jounce Therapeutics (JNCE), could be rewarding
3 Must-Own Undervalued Growth Stocks
While the growth stocks that skyrocketed over the past year have been experiencing a sell-off lately, there are a new set of stocks in the class that are poised to grow significantly with an economic recovery. While technology-sector growth stocks have yet to trade at reasonable valuations, there are “post-pandemic” growth names that are now significantly undervalued. PulteGroup (PHM), Tupperware Brands (TUP), and Ironwood Pharmaceuticals (IRWD) are three examples of such. We think they could see significant growth in the coming months. Let’s take a closer look at them.
Avoid These 2 Overvalued Renewable Chemical Stocks
Rising worldwide concerns about carbon emissions and climate change have illuminated the importance of curbing the carbon footprint of harmful chemicals. This is fueling the growth of the renewable chemicals market. However, Gevo (GEVO) and Aemetis (AMTX), companies that produce chemicals for renewable fuels and have thus far capitalized on bullish investor sentiment lack adequate growth in revenues and earnings to justify their current valuations. So, we believe these stocks are best avoided now. Read on.
Stay Away from These 3 Overvalued Healthcare Stocks
The healthcare industry has seen a faster-than-expected recovery following a decline in non-emergency patient volumes for most of 2020. However, because divided, partisan views regarding the future of healthcare in the United States are unsettling investors, we think overvalued stocks Teladoc Health (TDOC), Oak Street Health (OSH), and Invitae (NVTA) are best avoided for now.
2 Reddit Stocks (Not Named GameStop) That Wall Street Hates
The populist trading rally organized in Reddit’s online forum has helped attract a flood of retail cash into GameStop (GME), knocking out hedge funds that had bet against the stock. Fueled by the Reddit hype, speculative penny stocks AMC Entertainment Holdings, Inc. (AMC) and Tanger Factory Outlet Centers, Inc. (SKT) are currently trading at prices detached from their fundamentals. That’s why Wall Street analysts dislike them. Let’s take a closer look.
3 Growth Stocks You’ll Want to Own in 2021
Growth stocks tend to do well during economic recoveries. So, because the U.S. appears to have finally entered its economic recovery phase, supported by a recent federal support package and a turbo-charged coronavirus vaccination drive, we think Align Technology (ALGN), Horizon Therapeutics (HZNP), and Insperity (NSP), names that possess solid growth attributes, may deliver plenty upside. Let’s look closer at these companies.
2 Electric Vehicle Stocks Targeted by Short Sellers
After experiencing a breathtaking rally after the stock market's correction in March last year, electric vehicle (EV) stocks have started to sell-off lately. Because optimism surrounding the industry has caused some of the weaker players in the sector to be overvalued, these names are now attracting the attention of short sellers. Lordstown Motors (RIDE) and XL Fleet (XL) are two such stocks. Read on.